Report Thumbnail
Product Code QY0912908487VR
Published Date 2024/4/9
English122 PagesGlobal

Global Small Molecule Drug 3D Printing Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0912908487VR◆The Apr 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/4/9
English 122 PagesGlobal

Global Small Molecule Drug 3D Printing Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market



Abstract


Summary

Small Molecule Drug 3D Printing refers to a technology that involves the use of 3D printing techniques to fabricate pharmaceuticals containing small molecule drugs. Unlike traditional manufacturing methods where drugs are typically produced in bulk as tablets or capsules with uniform dosages, 3D printing allows for the creation of personalized medicine and complex dosage forms on a patient-by-patient basis. The global Small Molecule Drug 3D Printing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period. The US & Canada market for Small Molecule Drug 3D Printing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. The China market for Small Molecule Drug 3D Printing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. The Europe market for Small Molecule Drug 3D Printing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. The global key manufacturers of Small Molecule Drug 3D Printing include Aprecia, FabRx, Multiply Labs, Merck KGaA, Triastek, MSD, AstraZeneca, TNO, Multiply Labs, DiHeSys, etc. In 2023, the global top five players had a share approximately % in terms of revenue. Report Includes This report presents an overview of global market for Small Molecule Drug 3D Printing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Small Molecule Drug 3D Printing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Molecule Drug 3D Printing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Small Molecule Drug 3D Printing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Molecule Drug 3D Printing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Molecule Drug 3D Printing revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Aprecia, FabRx, Multiply Labs, Merck KGaA, Triastek, MSD, AstraZeneca, TNO, Multiply Labs, DiHeSys, etc. Market Segmentation By Company Aprecia FabRx Multiply Labs Merck KGaA Triastek MSD AstraZeneca TNO Multiply Labs DiHeSys Segment by Type Material Extrusion Binder Jetting Powder Bed Fusion Other Segment by Application Large-scale Production Personalized Pharmaceutical Concept Research and Technology Development By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Europe Germany France U.K. Italy Russia Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of South America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Small Molecule Drug 3D Printing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Small Molecule Drug 3D Printing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Molecule Drug 3D Printing revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

  • 1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Small Molecule Drug 3D Printing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
      • 1.2.2 Material Extrusion
      • 1.2.3 Binder Jetting
      • 1.2.4 Powder Bed Fusion
      • 1.2.5 Other
    • 1.3 Market by Application
      • 1.3.1 Global Small Molecule Drug 3D Printing Market Share by Application: 2019 VS 2023 VS 2030
      • 1.3.2 Large-scale Production
      • 1.3.3 Personalized Pharmaceutical
      • 1.3.4 Concept Research and Technology Development
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Small Molecule Drug 3D Printing Market Perspective (2019-2030)
    • 2.2 Global Small Molecule Drug 3D Printing Growth Trends by Region
      • 2.2.1 Global Small Molecule Drug 3D Printing Market Size by Region: 2019 VS 2023 VS 2030
      • 2.2.2 Small Molecule Drug 3D Printing Historic Market Size by Region (2019-2024)
      • 2.2.3 Small Molecule Drug 3D Printing Forecasted Market Size by Region (2025-2030)
    • 2.3 Small Molecule Drug 3D Printing Market Dynamics
      • 2.3.1 Small Molecule Drug 3D Printing Industry Trends
      • 2.3.2 Small Molecule Drug 3D Printing Market Drivers
      • 2.3.3 Small Molecule Drug 3D Printing Market Challenges
      • 2.3.4 Small Molecule Drug 3D Printing Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Revenue Small Molecule Drug 3D Printing by Players
      • 3.1.1 Global Small Molecule Drug 3D Printing Revenue by Players (2019-2024)
      • 3.1.2 Global Small Molecule Drug 3D Printing Revenue Market Share by Players (2019-2024)
    • 3.2 Global Small Molecule Drug 3D Printing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Global Key Players of Small Molecule Drug 3D Printing, Ranking by Revenue, 2022 VS 2023 VS 2024
    • 3.4 Global Small Molecule Drug 3D Printing Market Concentration Ratio
      • 3.4.1 Global Small Molecule Drug 3D Printing Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug 3D Printing Revenue in 2023
    • 3.5 Global Key Players of Small Molecule Drug 3D Printing Head office and Area Served
    • 3.6 Global Key Players of Small Molecule Drug 3D Printing, Product and Application
    • 3.7 Global Key Players of Small Molecule Drug 3D Printing, Date of Enter into This Industry
    • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Small Molecule Drug 3D Printing Breakdown Data by Type

    • 4.1 Global Small Molecule Drug 3D Printing Historic Market Size by Type (2019-2024)
    • 4.2 Global Small Molecule Drug 3D Printing Forecasted Market Size by Type (2025-2030)
  • 5 Small Molecule Drug 3D Printing Breakdown Data by Application

    • 5.1 Global Small Molecule Drug 3D Printing Historic Market Size by Application (2019-2024)
    • 5.2 Global Small Molecule Drug 3D Printing Forecasted Market Size by Application (2025-2030)
  • 6 North America

    • 6.1 North America Small Molecule Drug 3D Printing Market Size (2019-2030)
    • 6.2 North America Small Molecule Drug 3D Printing Market Size by Type
      • 6.2.1 North America Small Molecule Drug 3D Printing Market Size by Type (2019-2024)
      • 6.2.2 North America Small Molecule Drug 3D Printing Market Size by Type (2025-2030)
      • 6.2.3 North America Small Molecule Drug 3D Printing Market Share by Type (2019-2030)
    • 6.3 North America Small Molecule Drug 3D Printing Market Size by Application
      • 6.3.1 North America Small Molecule Drug 3D Printing Market Size by Application (2019-2024)
      • 6.3.2 North America Small Molecule Drug 3D Printing Market Size by Application (2025-2030)
      • 6.3.3 North America Small Molecule Drug 3D Printing Market Share by Application (2019-2030)
    • 6.4 North America Small Molecule Drug 3D Printing Market Size by Country
      • 6.4.1 North America Small Molecule Drug 3D Printing Market Size by Country: 2019 VS 2023 VS 2030
      • 6.4.2 North America Small Molecule Drug 3D Printing Market Size by Country (2019-2024)
      • 6.4.3 North America Small Molecule Drug 3D Printing Market Share by Country (2025-2030)
      • 6.4.4 United States
      • 6.4.5 Canada
  • 7 Europe

    • 7.1 Europe Small Molecule Drug 3D Printing Market Size (2019-2030)
    • 7.2 Europe Small Molecule Drug 3D Printing Market Size by Type
      • 7.2.1 Europe Small Molecule Drug 3D Printing Market Size by Type (2019-2024)
      • 7.2.2 Europe Small Molecule Drug 3D Printing Market Size by Type (2025-2030)
      • 7.2.3 Europe Small Molecule Drug 3D Printing Market Share by Type (2019-2030)
    • 7.3 Europe Small Molecule Drug 3D Printing Market Size by Application
      • 7.3.1 Europe Small Molecule Drug 3D Printing Market Size by Application (2019-2024)
      • 7.3.2 Europe Small Molecule Drug 3D Printing Market Size by Application (2025-2030)
      • 7.3.3 Europe Small Molecule Drug 3D Printing Market Share by Application (2019-2030)
    • 7.4 Europe Small Molecule Drug 3D Printing Market Size by Country
      • 7.4.1 Europe Small Molecule Drug 3D Printing Market Size by Country: 2019 VS 2023 VS 2030
      • 7.4.2 Europe Small Molecule Drug 3D Printing Market Size by Country (2019-2024)
      • 7.4.3 Europe Small Molecule Drug 3D Printing Market Size by Country (2025-2030)
      • 7.4.4 Germany
      • 7.4.5 France
      • 7.4.6 U.K
      • 7.4.7 Italy
      • 7.4.8 Russia
      • 7.4.9 Nordic Countries
  • 8 China

    • 8.1 China Small Molecule Drug 3D Printing Market Size (2019-2030)
    • 8.2 China Small Molecule Drug 3D Printing Market Size by Type
      • 8.2.1 China Small Molecule Drug 3D Printing Market Size by Type (2019-2024)
      • 8.2.2 China Small Molecule Drug 3D Printing Market Size by Type (2025-2030)
      • 8.2.3 China Small Molecule Drug 3D Printing Market Share by Type (2019-2030)
    • 8.3 China Small Molecule Drug 3D Printing Market Size by Application
      • 8.3.1 China Small Molecule Drug 3D Printing Market Size by Application (2019-2024)
      • 8.3.2 China Small Molecule Drug 3D Printing Market Size by Application (2025-2030)
      • 8.3.3 China Small Molecule Drug 3D Printing Market Share by Application (2019-2030)
  • 9 Asia (excluding China)

    • 9.1 Asia Small Molecule Drug 3D Printing Market Size (2019-2030)
    • 9.2 Asia Small Molecule Drug 3D Printing Market Size by Type
      • 9.2.1 Asia Small Molecule Drug 3D Printing Market Size by Type (2019-2024)
      • 9.2.2 Asia Small Molecule Drug 3D Printing Market Size by Type (2025-2030)
      • 9.2.3 Asia Small Molecule Drug 3D Printing Market Share by Type (2019-2030)
    • 9.3 Asia Small Molecule Drug 3D Printing Market Size by Application
      • 9.3.1 Asia Small Molecule Drug 3D Printing Market Size by Application (2019-2024)
      • 9.3.2 Asia Small Molecule Drug 3D Printing Market Size by Application (2025-2030)
      • 9.3.3 Asia Small Molecule Drug 3D Printing Market Share by Application (2019-2030)
    • 9.4 Asia Small Molecule Drug 3D Printing Market Size by Region
      • 9.4.1 Asia Small Molecule Drug 3D Printing Market Size by Region: 2019 VS 2023 VS 2030
      • 9.4.2 Asia Small Molecule Drug 3D Printing Market Size by Region (2019-2024)
      • 9.4.3 Asia Small Molecule Drug 3D Printing Market Size by Region (2025-2030)
      • 9.4.4 Japan
      • 9.4.5 South Korea
      • 9.4.6 China Taiwan
      • 9.4.7 Southeast Asia
      • 9.4.8 India
      • 9.4.9 Australia
  • 10 Middle East, Africa, and Latin America

    • 10.1 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size (2019-2030)
    • 10.2 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Type
      • 10.2.1 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Type (2019-2024)
      • 10.2.2 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Type (2025-2030)
      • 10.2.3 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Share by Type (2019-2030)
    • 10.3 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Application
      • 10.3.1 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Application (2019-2024)
      • 10.3.2 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Application (2025-2030)
      • 10.3.3 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Share by Application (2019-2030)
    • 10.4 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Country
      • 10.4.1 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Country: 2019 VS 2023 VS 2030
      • 10.4.2 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Country (2019-2024)
      • 10.4.3 Middle East, Africa, and Latin America Small Molecule Drug 3D Printing Market Size by Country (2025-2030)
      • 10.4.4 Brazil
      • 10.4.5 Mexico
      • 10.4.6 Turkey
      • 10.4.7 Saudi Arabia
      • 10.4.8 Israel
      • 10.4.9 GCC Countries
  • 11 Key Players Profiles

    • 11.1 Aprecia
      • 11.1.1 Aprecia Company Details
      • 11.1.2 Aprecia Business Overview
      • 11.1.3 Aprecia Small Molecule Drug 3D Printing Introduction
      • 11.1.4 Aprecia Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.1.5 Aprecia Recent Development
    • 11.2 FabRx
      • 11.2.1 FabRx Company Details
      • 11.2.2 FabRx Business Overview
      • 11.2.3 FabRx Small Molecule Drug 3D Printing Introduction
      • 11.2.4 FabRx Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.2.5 FabRx Recent Development
    • 11.3 Multiply Labs
      • 11.3.1 Multiply Labs Company Details
      • 11.3.2 Multiply Labs Business Overview
      • 11.3.3 Multiply Labs Small Molecule Drug 3D Printing Introduction
      • 11.3.4 Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.3.5 Multiply Labs Recent Development
    • 11.4 Merck KGaA
      • 11.4.1 Merck KGaA Company Details
      • 11.4.2 Merck KGaA Business Overview
      • 11.4.3 Merck KGaA Small Molecule Drug 3D Printing Introduction
      • 11.4.4 Merck KGaA Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.4.5 Merck KGaA Recent Development
    • 11.5 Triastek
      • 11.5.1 Triastek Company Details
      • 11.5.2 Triastek Business Overview
      • 11.5.3 Triastek Small Molecule Drug 3D Printing Introduction
      • 11.5.4 Triastek Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.5.5 Triastek Recent Development
    • 11.6 MSD
      • 11.6.1 MSD Company Details
      • 11.6.2 MSD Business Overview
      • 11.6.3 MSD Small Molecule Drug 3D Printing Introduction
      • 11.6.4 MSD Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.6.5 MSD Recent Development
    • 11.7 AstraZeneca
      • 11.7.1 AstraZeneca Company Details
      • 11.7.2 AstraZeneca Business Overview
      • 11.7.3 AstraZeneca Small Molecule Drug 3D Printing Introduction
      • 11.7.4 AstraZeneca Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.7.5 AstraZeneca Recent Development
    • 11.8 TNO
      • 11.8.1 TNO Company Details
      • 11.8.2 TNO Business Overview
      • 11.8.3 TNO Small Molecule Drug 3D Printing Introduction
      • 11.8.4 TNO Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.8.5 TNO Recent Development
    • 11.9 Multiply Labs
      • 11.9.1 Multiply Labs Company Details
      • 11.9.2 Multiply Labs Business Overview
      • 11.9.3 Multiply Labs Small Molecule Drug 3D Printing Introduction
      • 11.9.4 Multiply Labs Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.9.5 Multiply Labs Recent Development
    • 11.10 DiHeSys
      • 11.10.1 DiHeSys Company Details
      • 11.10.2 DiHeSys Business Overview
      • 11.10.3 DiHeSys Small Molecule Drug 3D Printing Introduction
      • 11.10.4 DiHeSys Revenue in Small Molecule Drug 3D Printing Business (2019-2024)
      • 11.10.5 DiHeSys Recent Development
  • 12 Analyst's Viewpoints/Conclusions

  • 13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
        • 13.1.1.1 Research Programs/Design
        • 13.1.1.2 Market Size Estimation
        • 13.1.1.3 Market Breakdown and Data Triangulation
      • 13.1.2 Data Source
        • 13.1.2.1 Secondary Sources
        • 13.1.2.2 Primary Sources
    • 13.2 Author Details
    • 13.3 Disclaimer
USD 4,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.